– Broad label inclusive of all ages and disease severities – – Launch to be initiated in Germany – WARREN, N.J., June 24, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that Sephience™ (sepiapterin) was granted marketing authorization by the European Commission...
Read More Details
Finally We wish PressBee provided you with enough information of ( Sephience™ (sepiapterin) Granted Marketing Authorization by the European Commission for the Treatment of Children and Adults Living with Phenylketonuria (PKU) )
Also on site :
- European militarization robbing taxpayers – Lavrov
- 'Golden Bachelor' Mel Owens Issues Bold Statement About Upcoming Season
- Tobey Maguire's 'Spider-Man' Trilogy Returns to Theaters With Rare Extended Cut